Grundzüge der medikamentösen Therapie und chirurgische Optionen bei Uveitis
Der Ophthalmologe · 2019-10 · 116 (10) · 942-950
DOI: 10.1007/s00347-019-0870-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Der Ophthalmologe, online erschienen am 22.02.2019. Verfasst von Justus G Garweg. Beteiligte Einrichtung: Berner Augenklinik am Lindenhofspital, Affiliation: Klinik und Poliklinik für Augenheilkunde, Inselspital, Universität Bern, Bremgartenstr 119, 3012,…. Hauptthemen laut MEDLINE: Uveitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Modern treatment of uveitis aims at a complete control of inflammatory activity, preservation of visual function and the prevention of secondary organ damage as a consequence of the underlying inflammatory disease and its treatment. OBJECTIVE: This article gives an update about the strategies of pharmacological and surgical options for uveitis. MATERIAL AND METHODS: The outcomes reported here are based on a PubMed search using the terms and . All prospective studies and case series with more than 20 cases as well as review articles from the last 5 years along with cited cross-references were evaluated. RESULTS: Local and systemic corticosteroids form the foundation of treatment after exclusion of an infectious etiology. If uveitis activity is not controlled within 6 weeks or if the daily corticosteroid dosage is unacceptably high, a treatment escalation using immunomodulatory drugs is required. If a complete control of inflammatory activity is not achieved, in a third phase treatment is supplemented by antibody-based treatment or cytokines, so-called biologics, with the aim of complete long-term freedom from disease without local or systemic steroid treatment. This target is achieved in 65-80% and guarantees long-term functional stability and anatomical integrity. Early treatment escalation in cases of persisting or recurrent activity as a rule prevents new secondary organ damage. Surgical options are utilized for diagnostic purposes, the administration of intravitreal drugs and for treatment of secondary complications. CONCLUSION: Just like the majority of immunological diseases, uveitis is a chronic disease requiring long-term and possibly lifelong treatment and remission (absence of inflammation without treatment) is achieved in only
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Berner Augenklinik am Lindenhofspital, Affiliation: Klinik und Poliklinik für Augenheilkunde, Inselspital, Universität Bern, Bremgartenstr 119, 3012, Bern, Schweiz. justus.garweg@swiss-eye-institute.com.
- Swiss Eye Institute, Rotkreuz, Schweiz. justus.garweg@swiss-eye-institute.com.
Zitieren
APA
Garweg, J. G. (2019). Grundzüge der medikamentösen Therapie und chirurgische Optionen bei Uveitis. Der Ophthalmologe, 116(10), 942-950. https://doi.org/10.1007/s00347-019-0870-x
Vancouver
Garweg JG. Grundzüge der medikamentösen Therapie und chirurgische Optionen bei Uveitis. Der Ophthalmologe. 2019;116(10):942-950. doi:10.1007/s00347-019-0870-x
BibTeX
@article{Garweg2019,
author = {Garweg, Justus G},
title = {Grundzüge der medikamentösen Therapie und chirurgische Optionen bei Uveitis},
journal = {Der Ophthalmologe},
year = {2019},
volume = {116},
number = {10},
pages = {942--950},
doi = {10.1007/s00347-019-0870-x}
}
EUVIMED